<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:mpath ids='MPATH_177'>Angiogenesis</z:mpath> plays an important role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development, progression, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Vascular endothelial growth factor (VEGF) is a key regulator of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the contribution of common VEGF polymorphisms to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) prognosis remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We have genotyped four polymorphisms of VEGF (-2578C&gt;A, -1154G&gt;A, -634G&gt;C, and 936C&gt;T) in 350 CRC cases from the Korean population </plain></SENT>
<SENT sid="4" pm="."><plain>The genotyping of VEGF polymorphisms was performed by polymerase chain reaction-restriction fragment length polymorphism assay </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Although not every VEGF polymorphism was significantly correlated with patient prognosis in overall 350 CRC patients, we found that the VEGF -2578CA genotype was associated with a significantly poor prognosis for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancers</z:e> compared to the CC genotype (HR = 2.156; 95 % CI 1.090-4.267; P = 0.028) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, we found that the -2578A/-1154G/-634G/+936C haplotype was significantly associated with a decreased overall survival (OS) rate in <z:hpo ids='HP_0000001'>all</z:hpo> 350 CRC patients (HR = 2.530; 95 % CI 1.340-4.780; P = 0.004) </plain></SENT>
<SENT sid="7" pm="."><plain>In combination analysis, we found that the combined VEGF -2578CA+AA/-1154GG genotype was associated with a poor OS rate in <z:hpo ids='HP_0000001'>all</z:hpo> 350 CRC patients (HR = 2.068; 95 % CI 1.159-3.693; P = 0.015) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The VEGF gene polymorphisms investigated in this study were not found to be independent prognostic markers in Korean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> populations </plain></SENT>
<SENT sid="9" pm="."><plain>However, our results suggest that the VEGF -2578C&gt;A variant may be a potential genetic marker for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> prognosis </plain></SENT>
<SENT sid="10" pm="."><plain>Further large population studies are warranted to define whether the -2578C&gt;A polymorphism is a prognostic marker of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>